Financing: Financed by CAPES, CNPq (305822/2025-0), and FAPERJ (E-26/202.524/2019; E-26/200.284/2023).
Disclosure of conflict of interest: We have no conflict of interest to declare.
Tiempo estimado de lectura: 2 min (261 palabras)
(Esta estimación no incluye el texto de las tablas, figuras y referencias)
Introduction: The consumption of ultra-processed foods (UPFs) has increased in recent decades and has been associated with poorer dietary quality, low-grade systemic inflammation, and higher cardiometabolic risk. As patients with dyslipidemia have increased cardiovascular risk, investigating the relationship between UPF intake and inflammatory and metabolic markers is relevant. The aim of this study was to evaluate the relationship between the frequency of UPF consumption and inflammatory and metabolic markers in patients with dyslipidemia. Methods: This cross-sectional study assessed dietary intake using three 24-hour dietary recalls on non-consecutive days and a food frequency questionnaire addressing 13 groups of UPFs most commonly consumed in Brazil. Blood samples were collected for routine biochemical tests, including Creactive protein (CRP). Results: Fifty-six patients participated in the study [50 years (IQR = 22.25); BMI 27.55 kg/m² (IQR = 6.62); 75% female]. More frequent consumption of specific UPFs was associated with higher inflammatory markers. Compared with non-consumers, individuals who consumed industrialized sauces, powdered soft drinks, and soft drinks ≥5 times/week had significantly higher CRP levels (p=0.01, p=0.0003, p=0.03, respectively). Similarly, margarine intake (3–4 times/week) was associated with higher CRP (p<0.0001) and a trend toward higher fibrinogen levels (p = 0.054). In addition, more frequent consumption of packaged savory biscuits was associated with higher uric acid levels (p = 0.02). Conclusion: In patients with dyslipidemia, higher UPF consumption was associated with adverse inflammatory and metabolic changes, reinforcing the importance of reducing UPF intake in cardiometabolic risk management.
Keywords: ultra-processed foods, inflammation, dyslipidemia
Financing: Financed by CAPES, CNPq (305822/2025-0), and FAPERJ (E-26/202.524/2019; E-26/200.284/2023).
Disclosure of conflict of interest: We have no conflict of interest to declare.
Artículo anterior
Calidad de la dieta y características antropométricas en adolescentes jugadores de futbol bandera
Siguiente artículo
Validación de instrumento de referencia comparando porciones teóricas y reales en productos lácteos y huevo.